Related Experiment Video

Updated: May 23, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Hypogonadism and infertility in testicular cancer survivors

Linda A Jacobs1, David J Vaughn

  • 1Abramson Cancer Center, University of Pennsylvania, The Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania 19104, USA. Linda.jacobs@uphs.upenn.edu

Journal of the National Comprehensive Cancer Network : JNCCN
|April 12, 2012
PubMed

Insights

Testicular cancer survivors face long-term risks of hypogonadism and infertility. Understanding the links between these conditions and cancer is crucial for developing better management strategies.

Area of Science:

  • Oncology
  • Endocrinology
  • Reproductive Medicine

Background:

  • Testicular cancer is the most common cancer in young men (20s-30s) and is highly curable.
  • Survivors' longer life expectancy necessitates addressing long-term health issues like hypogonadism and infertility.
  • Existing associations between hypogonadism, infertility, and testicular cancer suggest shared underlying causes, potentially including fetal development issues.

Purpose of the Study:

  • To explore the significant long-term health concerns of hypogonadism and infertility in testicular cancer survivors.
  • To investigate the impact of cancer treatments on hormonal levels (testosterone, LH, FSH) and fertility outcomes.
  • To highlight the need for evidence-based guidelines for managing testicular cancer survivors, considering their reproductive health.

Main Methods:

  • Review of existing literature on testicular cancer, hypogonadism, and infertility.
  • Analysis of hormonal changes (testosterone, luteinizing hormone, follicle-stimulating hormone) post-treatment.
  • Examination of fertility and paternity rates in testicular cancer survivors.

Main Results:

  • Testicular cancer survivors frequently experience hypogonadism and infertility, impacting quality of life.
  • Cancer treatments can significantly affect hormone levels and reproductive capacity.
  • The interconnectedness of these conditions points to common etiologic factors.

Conclusions:

  • Minimizing long-term health issues like hypogonadism and infertility is critical for testicular cancer survivors.
  • Further research into the biological mechanisms is essential for clinical guideline development.
  • Addressing reproductive health is a key component in the comprehensive management of testicular cancer survivors.

More Related Videos

Mouse Round Spermatid Injection08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

Related Concept Videos

Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...